MCCOLLUM JAMES W - Insider Non-Derivative Transactions at LENZ Therapeutics, Inc. (LENZ) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 7, 2025, MCCOLLUM JAMES W's relationship to LENZ Therapeutics, Inc. (LENZ) is Director, and currently has 10,500 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LENZ insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

MCCOLLUM JAMES W - Insider Non-Derivative Transactions of LENZ Common Stock

MCCOLLUM JAMES W - Insider Non-Derivative Transactions at LENZ

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 8, 2025	P -- (Common Stock)	10500	22.79	10500
May 14, 2024	P -- (Common Stock)	31332	15.99	525565
Mar 22, 2024	Acquisition -- (Common Stock)	95034	0	95034
Mar 22, 2024	Acquisition -- (Common Stock)	477600	0	477600
Mar 22, 2024	Acquisition -- (Common Stock)	16633	15.03	494233